Study of Chromosome 1q in Pediatric Ependymoma
Author Information
Author(s): Rand V, Prebble E, Ridley L, Howard M, Wei W, Brundler M-A, Fee B E, Riggins G J, Coyle B, Grundy R G
Primary Institution: Children's Brain Tumour Research Centre, University of Nottingham
Hypothesis
The study aims to investigate the role of 1q genes in intracranial pediatric ependymoma.
Conclusion
The study provides evidence that S100A6 and S100A4 are differentially expressed in clinically relevant subgroups of pediatric ependymoma.
Supporting Evidence
- Gain of 1q is one of the most common alterations in cancer and has been associated with adverse clinical behaviour in ependymoma.
- CHI3L1 and S100A10 were identified as the most upregulated genes in the relapse pair with de novo 1q gain.
- S100A6 significantly correlated with supratentorial tumours.
- S100A4 correlated with patients under the age of 3 years at diagnosis.
Takeaway
Researchers looked at a part of a chromosome to see how it affects brain tumors in kids, finding some proteins that change based on the type of tumor.
Methodology
The study used comparative genome hybridization and serial analysis of gene expression on tumor samples.
Participant Demographics
The study included pediatric patients, with a significant number under the age of 5.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website